Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications
- 1 October 2001
- journal article
- research article
- Published by Elsevier in Prostaglandins, Leukotrienes and Essential Fatty Acids
- Vol. 65 (4) , 191-196
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabeticProstaglandins & Other Lipid Mediators, 1999
- Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring methodProstaglandins & Other Lipid Mediators, 1999
- Elevation of the Thromboxane A2/Prostacyclin Ratio in Urine of Diabetic Mice Analyzed by Gas Chromatography/Selected Ion MonitoringProstaglandins & Other Lipid Mediators, 1998
- Analysis of the thromboxane/prostacyclin balance in human urine by gas chromatography/selected ion monitoring: abnormalities in diabeticsProstaglandins, Leukotrienes and Essential Fatty Acids, 1996
- Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disordersTrends in Pharmacological Sciences, 1991
- The eicosanoids and their biochemical mechanisms of actionBiochemical Journal, 1989
- 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.Proceedings of the National Academy of Sciences, 1986
- Synthesis and structure of the platelet aggregation factor thromboxane A2Nature, 1985
- Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet ActivationNew England Journal of Medicine, 1984
- Chemical stability of prostacyclin (PGI2) in aqueous solutionsProstaglandins, 1978